Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Charles A. Leath"'
Autor:
Kaitlyn Kincaid, Teresa K.L. Boitano, Matthew Scalise, Samantha Patton, Charles A. Leath, III, John M. Straughn, Jr., Haller J. Smith
Publikováno v:
Gynecologic Oncology Reports, Vol 52, Iss , Pp 101344- (2024)
Objective: We aimed to assess the impact of preoperative steroid administration and perioperative glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy. Methods: This retrospective cohort stud
Externí odkaz:
https://doaj.org/article/20702e923d824d749d9a05b3d01abe48
Autor:
Collin A. Sitler, Chunqiao Tian, Chad A. Hamilton, Michael T. Richardson, John K. Chan, Daniel S. Kapp, Charles A. Leath, Yovanni Casablanca, Christina Washington, Nicole P. Chappell, Ann H. Klopp, Craig D. Shriver, Christopher M. Tarney, Nicholas W. Bateman, Thomas P. Conrads, George Larry Maxwell, Neil T. Phippen, Kathleen M. Darcy
Publikováno v:
Cancers, Vol 16, Iss 5, p 1071 (2024)
Purpose: To investigate IMT use and survival in real-world stage IVB cervical cancer patients outside randomized clinical trials. Methods: Patients diagnosed with stage IVB cervical cancer during 2013–2019 in the National Cancer Database and treate
Externí odkaz:
https://doaj.org/article/073012a1d2714c759e8039228d8c9a8c
Autor:
Rebecca C. Arend, Carly B. Scalise, Jhalak Dholakia, Maahum Z. Kamal, Haley B. Thigpen, David Crossman, Warner K. Huh, Charles A. Leath III
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8238-8250 (2021)
Abstract Background Patients with high‐intermediate risk endometrial cancer (H‐IR EMCA) have an elevated risk of recurrence compared to low‐risk counterparts. Many H‐IR EMCA patients are treated with radiation or chemotherapy, but their overa
Externí odkaz:
https://doaj.org/article/88d7d8534aaa441ab511558f98f4d091
Autor:
Teresa K.L. Boitano, Mary A. Powell, Charles A. Leath, III, J. Michael Straughn, Jr., Isabel C. Scarinci
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100950- (2022)
Background: This study was performed to evaluate the barriers and facilitators associated with patient presentation for early stage (ES) versus advanced stage (AS) cervical cancer (CC). Methods: A mixed-method approach was used to collect quantitativ
Externí odkaz:
https://doaj.org/article/fd27dfd41bfa4ca299d6c07dc0840350
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100949- (2022)
In January 2021, the Society of Gynecologic Oncology (SGO) Clinical Practice and Education Committees launched a “Journal Club” webinar series to invite national experts to discuss literature pertaining to common clinical scenarios encountered by
Externí odkaz:
https://doaj.org/article/52357fbf8d1d49098f92e759492d8277
Publikováno v:
Clinical Practice and Cases in Emergency Medicine, Vol 4, Iss 2 (2020)
Case Presentation: We describe the presentation to the emergency department of a patient with recurrent ovarian cancer treated with bevacizumab with the complication of bowel perforation. Discussion: We review the frequency and outcomes of bevacizuma
Externí odkaz:
https://doaj.org/article/02e0a0b658774bc49abee6892e177ee6
Autor:
Anne R. Van Arsdale, Rebecca C. Arend, Maria J. Cossio, Britt K. Erickson, Yanhua Wang, David W. Doo, Charles A. Leath, Gary L. Goldberg, Gloria S. Huang
Publikováno v:
Cancer Medicine, Vol 7, Iss 3, Pp 616-625 (2018)
Abstract The objective of this study was to investigate the relationship of insulin‐like growth factor 2 (IGF2) expression and survival in women with uterine carcinosarcoma (UCS). Insulin‐like growth factor 2 protein expression was determined by
Externí odkaz:
https://doaj.org/article/c62a4213e7dc4d21ab06feaabd66b046
Publikováno v:
Gynecologic Oncology Reports, Vol 29, Iss , Pp 123-125 (2019)
Poly-ADP ribose polymerase inhibitors (PARPi) are a promising new treatment option for patients with ovarian cancer and are moderately emetogenic. Tolerance of therapy is paramount, and uncontrolled nausea and vomiting may limit use. Although most pa
Externí odkaz:
https://doaj.org/article/928dd2fbe16d473fa5e4e4363687c29a
Publikováno v:
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 17-19 (2017)
Externí odkaz:
https://doaj.org/article/33b488034a7e47a7858e8c7825fbd842
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:490-498